MedPath

Abnormal Vaginal Flora and Vaginal Lesions at Delivery: is There a Relationship?

Completed
Conditions
Vaginal Lesion
Interventions
Biological: Bacteriological analysis of vaginal sample
Registration Number
NCT01822782
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The main objective of this study is to assess whether the presence of abnormal vaginal flora (intermediate flora or vaginosis) is a risk factor for vaginal lesions at the time of delivery. For this, the primary endpoint will be the proportion of vaginal lesions according to the presence or absence of abnormal vaginal flora.

A more precise qualitative and quantitative study of vaginal flora isolated from pregnant women and its association with vaginal lesions will also be conducted.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1100
Inclusion Criteria
  • Pregnant women with a gestational age > 34 weeks delivering at the Nîmes University Hospital
Exclusion Criteria
  • Patient under judicial protection
  • Adult patient under any kind of guardianship
  • Patient refuses participation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControlsBacteriological analysis of vaginal sampleThe study population consists of all consecutive women meeting inclusion/exclusion criteria and delivering at the Nîmes University Hospital, France during an inclusion period of 6 months. "Controls" are classified as those without a vaginal lesion due to delivery.
CasesBacteriological analysis of vaginal sampleThe study population consists of all consecutive women meeting inclusion/exclusion criteria and delivering at the Nîmes University Hospital, France during an inclusion period of 6 months. "Cases" are classified as those with a vaginal lesion due to delivery.
Primary Outcome Measures
NameTimeMethod
Presence/absence of a vaginal lesion due to deliveryUpon delivery (Day 0)
Record of abnormal vaginal flora (presence/absence of Nugent's score > 3) in patient's medical fileUpon delivery (Day 0)

Record of routine analysis of vaginal samples during pregnancy will be used.

Secondary Outcome Measures
NameTimeMethod
Recorded qualitative and quantitative analysis of vaginal flora in patient's fileUpon delivery (Day 0)

Trial Locations

Locations (1)

CHU de Nîmes - Hôpital Universitaire Carémeau

🇫🇷

Nîmes Cedex 9, France

© Copyright 2025. All Rights Reserved by MedPath